Myasthenia gravis market across 7MM set to grow at 5.3% CAGR between 2024 and 2034, forecasts… EP News Bureau Jun 17, 2025 Growth driven by rising diagnosed prevalence and launch of late-stage pipeline therapies, despite pressure from biosimilar…
